Reports on cancer prevention, care and treatment from the American Association for Cancer Research annual meeting.

Detection of circulating tumor DNA after treatment is a strong indicator of colorectal cancer relapse.

Zongertinib, an experimental oral HER2 inhibitor, shrank tumors in a majority of previously treated patients.

Better control of the acne-like side effect can lead to significantly better treatment outcomes.

Previously trained models could expand the reach of machine learning-based cancer diagnosis.

Experts weigh in on the SCOTUS case that could decide access to cost-free preventive care, like cancer and hepatitis screenings, heart statins, and PrEP to prevent HIV.